Abstract:Fluctuating transcription factor (TF) networks are commonly assumed to be responsible for stochastic hematopoietic lineage choice. The PU.1 and Gata1 TF pair, driving granulocytic-monocytic (GM) versus megakaryocytic-erythroid (MegE) lineage choice, respectively, is the paradigmatic TF pair underlying this hypothesis. Lineage priming, reprogramming experiments, positive autoregulation and mutual cross-antagonism of PU.1 and Gata1 have led to the hypothesis that random ‘noisy' fluctuations in PU.1 and Gata1 expression will allow one factor ‘winning' over the other and thus to inducing lineage choice. However, this hypothesis is based on limited expression data. So far, TF expression mostly was measured at the mRNA level in discontinuous snapshot analysis. For a comprehensive understanding, quantification of protein levels before, during and after lineage choice would be required. We therefore developed novel knock-in mouse lines simultaneously expressing PU.1eYFP and Gata1mCHERRY fusion proteins from their endogenous genomic loci. FACS analysis of those phenotypically normal mice allows identification and prospective isolation of several new myeloid hematopoietic subpopulations. Long-term single cell tracking and the development of novel software tools enables us to estimate endogenous molecule numbers and to quantify TF expression kinetics and dynamics with high resolution. This approach provides the quantitative continuous data in living hematopoietic stem and progenitors cells required for testing the above mentioned hypothesis. It demonstrates that fluctuating PU.1 and Gata1 levels are not responsible for GM-MegE lineage decision making. Fluctuating transcription factor (TF) networks are commonly assumed to be responsible for stochastic hematopoietic lineage choice. The PU.1 and Gata1 TF pair, driving granulocytic-monocytic (GM) versus megakaryocytic-erythroid (MegE) lineage choice, respectively, is the paradigmatic TF pair underlying this hypothesis. Lineage priming, reprogramming experiments, positive autoregulation and mutual cross-antagonism of PU.1 and Gata1 have led to the hypothesis that random ‘noisy' fluctuations in PU.1 and Gata1 expression will allow one factor ‘winning' over the other and thus to inducing lineage choice. However, this hypothesis is based on limited expression data. So far, TF expression mostly was measured at the mRNA level in discontinuous snapshot analysis. For a comprehensive understanding, quantification of protein levels before, during and after lineage choice would be required. We therefore developed novel knock-in mouse lines simultaneously expressing PU.1eYFP and Gata1mCHERRY fusion proteins from their endogenous genomic loci. FACS analysis of those phenotypically normal mice allows identification and prospective isolation of several new myeloid hematopoietic subpopulations. Long-term single cell tracking and the development of novel software tools enables us to estimate endogenous molecule numbers and to quantify TF expression kinetics and dynamics with high resolution. This approach provides the quantitative continuous data in living hematopoietic stem and progenitors cells required for testing the above mentioned hypothesis. It demonstrates that fluctuating PU.1 and Gata1 levels are not responsible for GM-MegE lineage decision making.

T To Myeloid Lineage Reprogramming By The Synergistic Action Of C/Ebp And Pu.1.

Reprogramming of Committed T Cell Progenitors to Macrophages and Dendritic Cells by C/Ebp Alpha and Pu.1 Transcription Factors

Supplemental Data Stepwise Reprogramming of B Cells into Macrophages

Reprogramming of committed lymphoid cells by enforced transcription factor expression.

Coreceptor Gene Imprinting Governs Thymocyte Lineage Fate

Myeloid Lineage Choice is Not Controlled by the Pu.1-Gata1 Switch

C/EBPalpha directs monocytic commitment of primary myeloid progenitors

Early Myeloid Lineage Choice is Not Initiated by Random PU.1 to GATA1 Protein Ratios

Transcriptional establishment of cell-type identity: dynamics and causal mechanisms of T-cell lineage commitment.

TCF-1 and LEF-1 promote CD4+ T cell lineage choice by upregulating Myb (P4439)

Carm1-arginine methylation of the transcription factor C/EBPα regulates transdifferentiation velocity

Single-cell deletion analyses show control of pro-T cell developmental speed and pathways by Tcf7, Spi1, Gata3, Bcl11a, Erg, and Bcl11b

Tcf-1 and Lef-1 Act Upstream of Th-Pok to Promote the Cd4(+) T Cell Fate and Interact with Runx3 to Silence Cd4 in Cd8(+) T Cells

Redefining hematopoietic progenitor cells and reforming the hierarchy of hematopoiesis

Transcription Factor Hoxb5 Reprograms B Cells into Functional T Lymphocytes.

Tcf7 is an important regulator of the switch of self-renewal and differentiation in a multipotential hematopoietic cell line.

MEF2C and EBF1 Co-regulate B Cell-Specific Transcription

Bcl11b and combinatorial resolution of cell fate in the T-cell gene regulatory network

PU.1 and C/EBPα/β convert fibroblasts into macrophage-like cells

Transcriptional Regulatory Logic Orchestrating Lymphoid and Myeloid Cell Fate Decisions

Enhancer and Transcription Factor Dynamics during Myeloid Differentiation Reveal an Early Differentiation Block in Cebpa null Progenitors